Nippon Shinyaku Co Ltd - ESG Rating & Company Profile powered by AI
If you work at Nippon Shinyaku Co Ltd and you wish to licence your Sustainability aseessment, please get in touch. This webpage of Nippon Shinyaku Co Ltd was assembled by All Street Sevva using advanced AI. The SDG rating for Nippon Shinyaku Co Ltd represents the company's transparency towards the UN SDGs.
Nippon Shinyaku Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 8.0, social score of 8.0 and governance score of 4.0.
6.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 314 | Trulieve Cannabis Corp | 6.8 | High |
| 314 | Vicore Pharma Holding AB | 6.8 | High |
| 337 | Nippon Shinyaku Co Ltd | 6.7 | High |
| 337 | Calyxt Inc | 6.7 | High |
| 337 | CanSino Biologics Inc | 6.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Nippon Shinyaku Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd offer flexible work?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose water use targets?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Nippon Shinyaku Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Nippon Shinyaku Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Nippon Shinyaku Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Nippon Shinyaku Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Nippon Shinyaku Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Nippon Shinyaku Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Switzerland, and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs for urological diseases, inflammation and allergies, hematologic malignancies, cardiovascular and metabolic diseases, gastrointestinal disorders, and other diseases. The company's products include Zalutia for urinary disorder caused by benign prostatic; Eviprostat for prostatic hypertrophy; Bladderon for pollakisuria; Estracyt for prostate cancer; Cialis for erectile dysfunction; Vidaza for myelodysplastic syndrome; Cylocide for solid tumor and acute leukemia; CylocideN for relapsed and refractory acute leukemia and malignant lymphoma; Gazyva for humanized anti-CD20 monoclonal antibody; Defiterio sinusoidal obstruction syndrome; and Trisenox and Amnolake for relapsed and refractory acute promyelocytic leukemia. Nippon Shinyaku Co., Ltd.'s products also comprise Uptravi, Adcirca, and Opsumit for pulmonary arterial hypertension; VILTEPSO for muscular dystrophy; Lunabel LD and Lunabel ULD for dysmenorrhea; Erizas, a dry powder inhaler solution for allergic rhinitis; Azunol Gargle liquid, a gargling solution containing azulene; Isobide for oral osmotic diuresis/meniere's disease; Cephadol for vertigo; Livostin for allergic rhinitis and conjunctivitis; Regtect for maintaining alcohol abstinence; and Onetram and Tramal for cancer and chronic pain. In addition, it researches, develops, and markets drugs in the areas of gynecology, otorhinolaryngology, and orthopedics. Further, the company provides functional foods, such as health food ingredients, preservatives, protein preparations, supplements, and spice and condiments. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.